Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 5Recruiting 4Terminated 2Suspended 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Leukemia, Myeloid, Acute 10Breast Neoplasms 9Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Lung Neoplasms 6Glioblastoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Hematologic Neoplasms 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Ovarian Neoplasms 4Myelodysplastic Syndromes 4Multiple Myeloma 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Solid Tumor 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Neoplasm, Residual 2NSCLC 2

Interventions

HM781-36B 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × NSCLC × 90 days × Clear all
NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended
268 enrolled
Thoracic

NSCLC

NCT00280189 2026-04-14

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

University of Pittsburgh

Suspended
72 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡